Covid Vaccine Phase 3 Trial in USA Confirmed Efficacy

AstraZeneca confirmed Wednesday that his COVID-19 vaccine was very effective in preventing disease.

The Anglo-Swedish drugmaker has confirmed this based on more recent data after questions were raised about the interim results of its US clinical trial findings announced on Monday.

Key Comments:

“Positive results from the primary analysis of the phase III trial of AZD1222 in the US have confirmed the efficacy of the COVID vaccine.”

The vaccine was well tolerated and no safety concerns were identified“.

“There are 76% efficacy of the symptomatic covid vaccine“.

.

You may also like

Bitcoin price analysis
Top News
David

Bitcoin price analysis

The price of bitcoin (BTC) is faced with difficulties due to sales pressure. During the week, BTC decreased by 3%.